Langkjaer L - Search Results

1

Insulin analogues with improved absorption characteristics.

Brange J, Hansen JF, Langkjaer L, Markussen J, Ribel U, Sørensen AR. Brange J, et al. Among authors: langkjaer l. Horm Metab Res Suppl. 1992;26:125-30. Horm Metab Res Suppl. 1992. PMID: 1490679

2

Application of the euglycaemic clamp technique to bioassay of insulin analogues.

Vłlund A, Ribel U, Dam PL, Markussen J, Langkjaer L, Dolben J, Owens DR. Vłlund A, et al. Among authors: langkjaer l. Biologicals. 1992 Jun;20(2):135-42. doi: 10.1016/s1045-1056(05)80061-2. Biologicals. 1992. PMID: 1389109

3

NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.

Jørgensen S, Vaag A, Langkjaer L, Hougaard P, Markussen J. Jørgensen S, et al. Among authors: langkjaer l. BMJ. 1989 Aug 12;299(6696):415-9. doi: 10.1136/bmj.299.6696.415. BMJ. 1989. PMID: 2506998 Free PMC article. Clinical Trial.

4

Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30.

Markussen J, Diers I, Engesgaard A, Hansen MT, Hougaard P, Langkjaer L, Norris K, Ribel U, Sørensen AR, Sørensen E, et al. Markussen J, et al. Among authors: langkjaer l. Protein Eng. 1987 Jun;1(3):215-23. doi: 10.1093/protein/1.3.215. Protein Eng. 1987. PMID: 3333847

5

Insulin formulation and delivery.

Brange J, Langkjaer L. Brange J, et al. Among authors: langkjaer l. Pharm Biotechnol. 1997;10:343-409. doi: 10.1007/0-306-46803-4_13. Pharm Biotechnol. 1997. PMID: 9160379 Review. No abstract available.

6

Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment.

Langkjaer L, Brange J, Grodsky GM, Guy RH. Langkjaer L, et al. J Control Release. 1998 Jan 23;51(1):47-56. doi: 10.1016/s0168-3659(97)00155-7. J Control Release. 1998. PMID: 9685903

7

Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30.

Markussen J, Diers I, Hougaard P, Langkjaer L, Norris K, Snel L, Sørensen AR, Sørensen E, Voigt HO. Markussen J, et al. Among authors: langkjaer l. Protein Eng. 1988 Jul;2(2):157-66. doi: 10.1093/protein/2.2.157. Protein Eng. 1988. PMID: 3072564

8

Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations.

Brange J, Langkjaer L, Havelund S, Vølund A. Brange J, et al. Among authors: langkjaer l. Pharm Res. 1992 Jun;9(6):715-26. doi: 10.1023/a:1015835017916. Pharm Res. 1992. PMID: 1409351

9

Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.

Brange J, Langkjaer L. Brange J, et al. Among authors: langkjaer l. Acta Pharm Nord. 1992;4(3):149-58. Acta Pharm Nord. 1992. PMID: 1418641

10

Precipitation of insulin aspart and insulin glulisine products used for continuous subcutaneous insulin infusion.

Poulsen C, Langkjaer L, Worsøe C. Poulsen C, et al. Among authors: langkjaer l. Diabetes Technol Ther. 2007 Feb;9(1):26-35. doi: 10.1089/dia.2006.0054. Diabetes Technol Ther. 2007. PMID: 17316095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters